Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$24.40 USD

24.40
1,722,894

+0.96 (4.10%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $24.42 +0.02 (0.08%) 7:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

New Strong Sell Stocks for April 27th

by Zacks Equity Research

FBC, IDCC, PAAS, COG, and QDEL have been added to the Zacks Rank #5 (Strong Sell) List on April 27, 2021

Zacks Equity Research

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $119.01, moving -0.42% from the previous trading session.

Zacks Equity Research

Quidel (QDEL) Stock Moves -0.28%: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $129.24 in the latest trading session, marking a -0.28% move from the prior day.

Zacks Equity Research

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $128.33, moving -1.47% from the previous trading session.

Zacks Equity Research

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $130.31 in the latest trading session, marking a +1.86% move from the prior day.

Zacks Equity Research

Quidel (QDEL) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Quidel (QDEL) closed at $126.30, marking a +0.13% move from the previous day.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

by Kevin Cook

Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales

Zacks Equity Research

Quidel (QDEL) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $138.90, moving -1.53% from the previous trading session.

Zacks Equity Research

Quidel (QDEL) Q4 Earnings Top Estimates

by Zacks Equity Research

Quidel (QDEL) delivered earnings and revenue surprises of 9.60% and -0.03%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Quidel Corp (QDEL) Might Surprise This Earnings Season

by Zacks Equity Research

Quidel Corp (QDEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

by Kevin Cook

Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations

Zacks Equity Research

Quidel (QDEL) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed the most recent trading day at $236.38, moving +1.5% from the previous trading session.

Zacks Equity Research

Why Quidel (QDEL) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.

Zacks Equity Research

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $236.85 in the latest trading session, marking a +1.29% move from the prior day.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

by Urmimala Biswas

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Zacks Equity Research

Quidel (QDEL) Stock Moves -0.87%: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day.

Zacks Equity Research

QIAGEN (QGEN) Announces COVID-19 Test Updates as Cases Rise

by Zacks Equity Research

QIAGEN (QGEN) along with with Australia-based digital diagnostics company, Ellume develops QIAreach SARS-CoV-2 Antigen Test.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for January 25th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 25th

Zacks Equity Research

Boston Scientific (BSX) Enhances Core Business With Buyout

by Zacks Equity Research

Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.

Zacks Equity Research

Integra (IART) Acquires Acell, Focuses on Regenerative Space

by Zacks Equity Research

The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic

Zacks Equity Research

Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays

by Zacks Equity Research

Globus Medical's (GMED) recent product launches are seeing tremendous uptake.

Urmimala Biswas headshot

Federal, Private Tie-Ups Boost COVID-19 Testing Volume

by Urmimala Biswas

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

Zacks Equity Research

Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens

by Zacks Equity Research

Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.